Angioedema induced by tramadol—a potentially life-threatening condition

Highlights of the 22nd French pharmacovigilance meeting (2002) Prescrire Int 57:21–23Google Scholar

Withdrawal syndrome and dependence: tramadol too (2003) Prescrire Int 65:99–100Google Scholar

Agostoni A, Cicardi M (2001) Drug-induced angioedema without urticaria. Drug Saf 8:599–606Google Scholar

Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J (1999) Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 8-9:1078–1087CrossRefGoogle Scholar

Barsotti CE, Mycyk MB, Reyes J (2003) Withdrawal syndrome from tramadol hydrochloride. Am J Emerg Med 1:87–88CrossRefGoogle Scholar

Dean DE, Schultz DL, Powers RH (2001) Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 5:1239–1243Google Scholar

Desmeules JA (2000) The tramadol option. Eur J Pain 4(suppl A):15–21CrossRefGoogle Scholar

Devulder J, De Laat M, Dumoulin K, Renson A, Rolly G (1996) Nightmares and hallucinations after long-term intake of tramadol combined with antidepressants. Acta Clin Belg 3:184–186Google Scholar

Gadban H, Gilbey P, Talmon Y, Samet A (2003) Acute edema of the tongue: a life-threatening condition. Ann Otol Rhinol Laryngol 7:651–653Google Scholar

Grossman E, Messerli FH, Neutel JM (2000) Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors? Arch Intern Med 13:1905–1911CrossRefGoogle Scholar

Hedenmalm K, Lindh JD, Sawe J, Rane A (2004) Increased liability of tramadol–warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Eur J Clin Pharmacol 5:369–372Google Scholar

Houlihan DJ (2004) Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann Pharmacother 3:411–413Google Scholar

Howes LG, Tran D (2002) Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 2:73–76Google Scholar

Kaya T, Gursoy S, Karadas B, Sarac B, Fafali H, Soydan AS (2003) High-concentration tramadol-induced vasodilation in rabbit aorta is mediated by both endothelium-dependent and -independent mechanisms. Acta Pharmacol Sin 5:385–389Google Scholar

Keeley PW, Foster G, Whitelaw L (2000) Hear my song: auditory hallucinations with tramadol hydrochloride. BMJ 7276:1608CrossRefGoogle Scholar

Klotz U (2003) Tramadol—the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain. Arzneimittelforschung 10:681–687Google Scholar

Mahlberg R, Kunz D, Sasse J, Kirchheiner J (2004) Serotonin syndrome with tramadol and citalopram. Am J Psychiatry 6:1129CrossRefGoogle Scholar

Meseguer Ruiz VA, Navarro Lopez V (2003) Auditive and visual hallucinations secondary to tramadol administration. Ann Med Interne 9:493Google Scholar

Mittino D, Mula M, Monaco F (2004) Serotonin syndrome associated with tramadol-sertraline coadministration. Clin Neuropharmacol 3:150–151CrossRefGoogle Scholar

Naslund S, Dahlqvist R (2003) Treatment with tramadol can give rise to dependence and abuse. Lakartidningen 9:712–714Google Scholar

Regoli D (1984) Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system. J Cardiovasc Pharmacol 6(suppl 2):S401–S412Google Scholar

Sabbe JR, Sims PJ, Sims MH (1998) Tramadol–warfarin interaction. Pharmacotherapy 4:871–873Google Scholar

Senay EC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Woody GE, Cicero TJ (2003) Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 3:233–241CrossRefGoogle Scholar

Shipton EA (2000) Tramadol—present and future. Anaesth Intensive Care 4:363–374Google Scholar